Skip to Main Navigation

Accelerating Genomics-based Surveillance for Disease-Causing Pathogens in South Africa

Development Objective

The project development objective (PDO) is to improve genomic surveillance capacity of infectious diseases in South Africa and the Africa region.

Key Details

Project Details

  • P177439

  • Active

  • Wezi Msisha , Toni Kuguru

  • Stellenbosch University

  • South Africa

  • December 9, 2021

  • (as of board presentation)

    April 11, 2022

  • June 20, 2022

  • US$ 5.00 million

  • Centre for Epidemic Response and Innovation

  • Eastern and Southern Africa

  • 2022

  • US$ 5.00 million

  • N/A

  • June 25, 2024

  • March 31, 2026

  • Yes

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Health Emergency Preparedness and Response Multi-Donor Trust 5.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment N/A
IBRD + IDA Commitment N/A
Lending Instrument
Grant Amount 5.00
Total Project Cost** 5.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Satisfactory 2024-11-25
Overall Implementation Progress (IP) Satisfactory 2024-11-25
Progress towards achievement of PDO Satisfactory 2024-11-25
Progress towards achievement of PDO Satisfactory 2024-11-25
Overall Implementation Progress (IP) Satisfactory 2024-11-25
Overall Implementation Progress (IP) Satisfactory 2024-11-25

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of reagents to be procured for generating sequencing dataValue0.00492.0018000.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Volume of reagents to be procured for analysis of diagnostic and vaccine effectivenessValue0.000.002000.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Number of sequences produced in South Africa and African regionValue0.008154.0020000.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Number of staff and scientists who are able to produce genomic sequencing data.Value0.0071.0050.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Number of staff and scientists who are able to analyze genomic sequencing data.Value0.0071.0050.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of meetings heldValue0.0035.0033.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Turnaround time of producing sequencing dataValue>15 days>15 days<15 days
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Number of training sessions organized for capacity building of genomic sequencing data generationValue0.005.004.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Operational protocol for rapid transportation of samples is developedValue0.001.001.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Analytical protocol for evaluating the effectiveness of diagnostics and vaccines is developedValue0.001.001.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • A dashboard is produced to provide weekly update of genomic data and synthesis information on epidemiological and clinical and vaccination dataValue0.001.001.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment
  • Number of training sessions organized for capacity building of genomic sequencing data analysisValue0.005.004.00
    DateFebruary 1, 2022August 15, 2023March 31, 2025
    Comment